Sinovac Biotech

SINOVAC has started enrolling participants aged 40+ in Phase I/II trials for our mRNA Shingles vaccine. #ClinicalTrials #Shingles #Vaccines

We are proud to continue supporting Chile's vaccination campaign for the second year! Our influenza vaccine, ANFLU®, provides robust protection against Influenza A (H1N1), A (H3N2), and B viruses. #PublicHealth #InfluenzaVaccine #VaccinationCampaign #GlobalHealth

Excited to announce the launch of SINOVAC's adsorbed tetanus vaccine! Improved safety & immunogenicity through innovation. Committed to advancing public health. #Tetanus #Innovation #PublicHealth #Sinovac

Advancing protection against Varicella-Zoster Virus (VZV)! 🚀 At SINOVAC, we're proud of our 2025 milestones. Committed to global health and vaccine innovation! #HealthInnovation #Sinovac #VaccineExcellence #GlobalHealth

Season’s Greetings from SINOVAC! 🎉 Thank you for your support and trust. Wishing you peace, warmth, and a bright year ahead! ✨ #SINOVAC #SeasonGreetings #HappyHolidays #GlobalHealth #Community #Wellness #NewYear2026

Strengthening ties with Ghana 🇬🇭 at SINOVAC. The National Vaccine Institute (NVI) of Ghana collaborates with SINOVAC on vaccines and expands local partnerships. Together to eliminate diseases and improve health across the continent. #Health #Africa #BeyondBorders

SINOVAC and @biofarmaID Join Forces for Global Health 🌏 SINOVAC visited Bio Farma's headquarters in Bandung, Indonesia. Both parties reaffirmed their commitment to strengthening long-term strategic cooperation to advance global health initiatives. #GlobalHealth #BeyondBorders

🌟 Major breakthrough in influenza protection! SINOVAC’s QIV shows safety, humoral, & cellular responses—may confer durable protection. Proud to advance vaccines that help create a healthier world. 🚀 #TheSinovacEffect #VaccineInnovation #GlobalHealth

Tomorrow, we mark Universal Health Coverage Day 2025. At SINOVAC, we're committed to making vaccines more accessible & affordable, working towards a future where everyone has quality healthcare.#UniversalHealthCoverage #HealthForAll #VaccinesForAll #GlobalHealth

SINOVAC VP meets Brazilian leaders to boost local vaccine production—advancing access to human rabies and varicella vaccines and strengthening #Brazil-#China health cooperation. Together, we’re taking a step toward vaccine access and health independence. #vaccine #GlobalHealth

El Panel 2: Innovación, Tecnología y Ciencia 🇨🇴🇨🇳 reunió a expertos cómo Angela Cortés de @Ministerio_TIC , Pedro Romero de @Huawei_Colombia , Juan Carlos Trujillo de @Sinovac y Gao Yuan @alibaba_cloud bajo la moderación de José Carlos García de @ELTIEMPO.

How many lives have vaccines saved worldwide? A new Lancet study reveals: 154 million. #Immunization #Vaccine #GlobalHealth

✨ Exciting news from SINOVAC! 🎉 Our self-developed Recombinant Zoster (Shingles) Vaccine (CHO cell) has received clinical approval from the NMPA of China! Stay tuned for more updates! 💉 #vaccine #shingles #HealthInnovation

Does SINOVAC have vaccines that are WHO-prequalified? Yes, multiple! Not just one. #Vaccine #GlobalHealth

SINOVAC’s partner in #Brazil, @TecparBR, held the first meeting to discuss local rabies vaccine production, just a day after signing with Brazil’s Ministry of Health. VP Weining Meng joined to advance tech transfer—another step toward vaccine access via SUS! #PublicHealth

A delegation from Indonesia’s @biofarmaID , led by Dr. Roni Dwi Susanto & Yuliana Indriati, visited SINOVAC to discuss the ongoing vaccine partnership. Praised SINOVAC’s WHO-prequalified polio vaccine. Looking forward to strengthening our collaboration for global health!

#SINOVAC signs 2 PDPs in #Brazil to boost local vaccine production: resuming #rabies #vaccine manufacturing with Tecpar & expanding #varicella supply. Strengthening Brazil’s health security and vaccine sovereignty. #TheSinovacEffect 🚀 #VaccineIndependence #PublicHealth

Is there an international standard to trust the safety of vaccines or medicines? Yes, it’s WHO prequalification (PQ). #WHO #Vaccine #GlobalHealth

Both parties agree to improve cooperation and communication for global health. We believe that global collaboration is essential to accelerate efforts toward equitable vaccine access for all and to advance global health outcomes.

SINOVAC is dedicated to leveraging technology and innovation to eliminate diseases. Emphasizing collaboration through the BRICS Vaccine R&D Center, Mr. Meng highlighted the importance of partnerships in making vaccines more accessible and affordable.

Recently, we welcomed the Indonesian delegation led by Mr. Masni Eriza, Chief Strategist of the Center for Multilateral Policy Strategy, Foreign Policy Strategy Agency, Ministry of Foreign Affairs of Indonesia. #ScalingForHealth #SinovacShapingHealth #BeyondBoarders